H. Jernström

Å. Borg, H. Jernström, H. Olsson, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

F. Couch, B. Bonanni, T. Rebbeck, 2011, British Journal of Cancer.

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort

C. Ingvar, C. Rose, M. Persson, 2016, British Journal of Cancer.

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

D. Horsman, W. Foulkes, B. Weber, 2004, Journal of the National Cancer Institute.

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment

K. Jirström, K. Isaksson, H. Jernström, 2020, Virchows Archiv.

Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.

T. Klug, S. Narod, H. Jernström, 2003, Carcinogenesis.

Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women.

H. Jernström, M. Henningson, H. Olsson, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.

Å. Borg, N. Loman, H. Olsson, 2005, European journal of cancer.

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study

H. Jernström, S. Borgquist, M. Inasu, 2022, Breast.

CYP 17 genotype is associated with short menstrual cycles , early oral contraceptive use and BRCA mutation status in young healthy women

Å. Borg, H. Jernström, M. Henningson, 2007 .

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

K. Jirström, K. Isaksson, A. Bosch, 2022, Translational oncology.

Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families

Å. Borg, H. Jernström, H. Olsson, 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer

H. Jernström, H. Olsson, B. Holmqvist, 2016, Breast cancer.

Reproductive factors in hereditary breast cancer

Å. Borg, N. Loman, H. Olsson, 1999, Breast Cancer Research and Treatment.

No Significant Difference in Age at Menarche, Menstrual Cycle Length, Age at First Full-Term Pregnancy, and Nulliparity Among BRCA1 Mutation Carriers Compared with Their Unaffected Relatives

Å. Borg, O. Johannsson, H. Jernström, 2001 .

Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years.

H. Jernström, H. Olsson, 1997, American journal of epidemiology.

Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events

C. Ingvar, P. Bendahl, C. Rose, 2014, SpringerPlus.

Familial and hormonal risk factors for papillary serous uterine cancer.

M. Carey, A. Fyles, S. Narod, 2002, European journal of gynaecological oncology.

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort

K. Jirström, C. Ingvar, C. Rose, 2016, Clinical Cancer Research.

Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer

H. Jernström, M. Henningson, U. Johansson, 2008, British Journal of Cancer.

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

C. Ingvar, C. Rose, M. Simonsson, 2013, Cancer Causes & Control.

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study

K. Jirström, C. Ingvar, M. Pollak, 2021, Frontiers in Oncology.

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.

S. Narod, C. Deal, M. Pollak, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors

H. Olsson, C. Ingvar, P. Jönsson, 2005, Breast Cancer Research and Treatment.

Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites.

T. Klug, S. Narod, H. Jernström, 2006, Molecular genetics and metabolism.

Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives.

H. Jernström, H. Olsson, 1994, Gynecologic and obstetric investigation.

Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women.

H. Jernström, H. Olsson, 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels.

T. Klug, C. Ingvar, C. Rose, 2006, Molecular genetics and metabolism.

Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

S. Narod, H. Jernström, D. Vesprini, 2001, Journal of the National Cancer Institute.

Do BRCA1 mutations affect the ability to breast feed? Significantly shorter length of breast feeding among BRCA1 mutation carriers compared with their unaffected relatives.

Å. Borg, O. Johannsson, H. Jernström, 1998 .

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

C. Ingvar, C. Rose, Srinivas Veerla, 2016, BMC Cancer.

Plasma Prolactin and IGF-1 Levels in Young, Healthy, Nulliparous Women in Relation to Low Dose Oral Contraceptive Use

H. Jernström, L. Olsson, 1996 .

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment

K. Jirström, C. Ingvar, C. Rose, 2018, Front. Endocrinol..

Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study

H. Jernström, H. Olsson, Carolina Ellberg, 2011, Breast Cancer Research and Treatment.

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?

K. Isaksson, H. Jernström, C. Ceberg, 2022, Oncotarget.

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Mårten Fernö, Helena Jernström, Christian Ingvar, 2015, EMBO molecular medicine.

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

Helena Jernström, Lisa Rydén, S. Gruvberger-Saal, 2015, PloS one.

Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort

Å. Borg, H. Olsson, P. Broberg, 2015, Genes, chromosomes & cancer.

BRCA1-positive patients are small for gestational age compared with their unaffected relatives.

Å. Borg, O. Johannsson, H. Olsson, 1998, European journal of cancer.

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort

M. Dorkhan, H. Jernström, S. Borgquist, 2014, Cancer Causes & Control.

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients

C. Ingvar, C. Rose, P. Jönsson, 2009, British Journal of Cancer.

IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer

H. Jernström, M. Henningson, H. Olsson, 2011, Familial Cancer.

IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer

H. Jernström, M. Henningson, H. Olsson, 2011, Familial Cancer.

Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families

Å. Borg, H. Jernström, M. Henningson, 2007, Familial Cancer.

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families

Å. Borg, H. Jernström, H. Olsson, 2005, British Journal of Cancer.

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer

C. Ingvar, C. Rose, L. Zeng, 2015, Clinical Cancer Research.

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

O. Olopade, W. Foulkes, J. Brunet, 1999, The Lancet.

Reduced testosterone, 17β-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients

Å. Borg, H. Jernström, H. Olsson, 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk

H. Jernström, H. Olsson, M. Hietala, 2007, Familial Cancer.

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients

K. Jirström, C. Ingvar, C. Rose, 2018, Front. Oncol..

Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden

C. Ingvar, C. Rose, P. Jönsson, 2011, Acta oncologica.

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.

S. Narod, C. Deal, M. Pollak, 2001, Molecular genetics and metabolism.

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

C. Ingvar, C. Rose, Srinivas Veerla, 2016, BMC Cancer.

Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families

H. Jernström, H. Olsson, Carolina Ellberg, 2018, Cancer Causes & Control.

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients

C. Ingvar, C. Rose, M. Simonsson, 2014, International journal of cancer.

Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort

C. Ingvar, C. Rose, A. Ringberg, 2012, Cancer Causes & Control.

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

G Rennert, N Weerasooriya, K Offit, 2009, British Journal of Cancer.

Caffeine and caffeic acid inhibit growth and modify estrogen receptor ( ER ) and insulin-like growth factor I receptor ( IGF-IR ) levels in human breast cancer

C. Ingvar, C. Rose, L. Zeng, 2014 .

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

S. Cross, M. Lux, A. Olshan, 2023, Research square.

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

K. Jirström, C. Ingvar, C. Rose, 2017, Front. Endocrinol..

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups

K. Jirström, C. Ingvar, C. Rose, 2016, Oncotarget.

Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.

H. Jernström, H. Olsson, M. Knutsson, 1992, Contraception.

Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status

C. Ingvar, C. Rose, H. Jernström, 2008, Cancer Epidemiology Biomarkers & Prevention.

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis

C. Ingvar, K. Isaksson, C. Rose, 2018, Cancer Causes & Control.

Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study

K. Jirström, K. Isaksson, A. Bosch, 2021, Carcinogenesis.

The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer

K. Isaksson, Andrea Markkula, H. Jernström, 2019, Cancer Causes & Control.

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients

K. Jirström, K. Isaksson, S. Kimbung, 2020, Breast Cancer Research.

The prognostic impact of COX‐2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

K. Jirström, C. Ingvar, C. Rose, 2017, International journal of cancer.

Emergency cesarean sections can be predicted by markers for stress, worry and sleep disturbances in first‐time mothers

H. Jernström, M. Östman, J. Molin, 2011, Acta obstetricia et gynecologica Scandinavica.

Of cup and bra size: Reply to a prospective study of breast size and premenopausal breast cancer incidence

Helena Jernström, Christian Ingvar, C. Ingvar, 2006, International journal of cancer.

[Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment].

C. Ingvar, C. Rose, H. Jernström, 2005, Lakartidningen.

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients

C. Ingvar, C. Rose, H. Jernström, 2011, British Journal of Cancer.

Emergency Cesarean Sections Can Be Predicted by Markers for Stress, Worry, and Sleep Disturbances in First-time Mothers

H. Jernström, M. Östman, J. Molin, 2012 .

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

C. Agardh, P. Bendahl, J. Lidfeldt, 2003, Cancer Causes & Control.

Patients’ and physicians’ disagreement on patients’ understanding of clinical cancer trial information: a pairwise pilot study of mirroring subjective assessments compared with objective measurements

H. Jernström, M. Nilbert, P. Dellson, 2019, Trials.

Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study

K. Nilsson, H. Jernström, P. Dellson, 2018, Trials.

Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

I. Nabi, O. Gluz, K. Jirström, 2020, Molecular Cancer Research.

Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women

C. Ingvar, C. Rose, H. Jernström, 2007, British Journal of Cancer.

Prevalence of urinary incontinence in relation to self-reported depression, intake of serotonergic antidepressants, and hormone therapy in middle-aged women: a report from the Women's Health in the Lund Area study

J. Lidfeldt, C. Nerbrand, G. Samsioe, 2005, Menopause.

Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort

C. Ingvar, C. Rose, Andrea Markkula, 2012, Cancer Prevention Research.

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

P. Bendahl, H. Jernström, S. Borgquist, 2017, Breast Cancer Research and Treatment.

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

K. Isaksson, A. Bosch, M. Belting, 2023, Breast Cancer Research and Treatment.

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study

D. Edwards, K. Jirström, K. Isaksson, 2021, Frontiers in Oncology.

Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort

C. Ingvar, C. Rose, A. Ringberg, 2012, Cancer Causes & Control.

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

C. Ingvar, C. Rose, M. Simonsson, 2014, BMC Cancer.

IGF1 and IGFBP3 Polymorphisms and Plasma Levels in Women

H. Jernström, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Understanding the genetic complexity of puberty timing across the allele frequency spectrum

M. P. Concas, M. Jarvelin, E. Demerath, 2023, medRxiv.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

S. Rosset, W. He, S. Cross, 2023, Journal of Medical Genetics.

Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

O. Melander, M. Magnusson, E. Ahlqvist, 2023, Scientific Reports.

Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer – an observational study

H. Jernström, H. Olsson, E. Sand, 2018, BMC Cancer.

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis

C. Ingvar, K. Isaksson, C. Rose, 2018, Cancer Causes & Control.

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

Jack A. Taylor, S. Cross, C. Vachon, 2023, Breast Cancer Research.

Abstract LB-194: AhR Arg554Lys impacts tumor ER expression and endocrine treatment response in breast cancer

C. Ingvar, C. Rose, M. Simonsson, 2016 .

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

V. Pankratz, F. Couch, O. Olopade, 2010, Cancer research.

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

F. Couch, O. Olopade, T. Rebbeck, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer : the Malmö Diet and Cancer Cohort

M. Dorkhan, H. Jernström, S. Borgquist, 2017 .

Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.

H. Jernström, H. Olsson, Carolina Ellberg, 2012, Breast cancer research and treatment.

Emergency cesarean sections can be predicted by markers for stress, worry and sleep disturbances in first‐time mothers

H. Jernström, M. Östman, J. Molin, 2011, Acta obstetricia et gynecologica Scandinavica.

Breast Cancer -targets and Therapy Dovepress the Absence of Aldehyde Dehydrogenase 1 A1-positive Cells in Benign Mammary Stroma Is Associated with Risk Factors for Breast Cancer

H. Jernström, H. Olsson, B. Holmqvist, 2022 .

A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

Jack A. Taylor, C. Vachon, K. Czene, 2023, Human Mutation.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

Jaana M. Hartikainen, C. Vachon, K. Czene, 2024, medRxiv.

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

C. Ingvar, C. Rose, M. Simonsson, 2013, Cancer Causes & Control.

No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients

C. Ingvar, C. Rose, Andrea Markkula, 2014, Acta oncologica.

The Vitamin D Receptor as a Prognostic Marker in Breast Cancer—A Cohort Study

K. Isaksson, H. Jernström, L. Huss, 2024, Nutrients.

Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women.

H. Jernström, M. Henningson, H. Olsson, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.

H. Jernström, M. Henningson, H. Olsson, 2011, Molecular genetics and metabolism.

Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events

C. Ingvar, C. Rose, M. Simonsson, 2013, SpringerPlus.

IGF1 and IGFBP3 Polymorphisms and Plasma Levels in Women

H. Jernström, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients.

K. Isaksson, Sofie Björner, H. Jernström, 2023, Clinical breast cancer.

Understanding the genetic complexity of puberty timing across the allele frequency spectrum

M. P. Concas, J. Murabito, S. Bandinelli, 2024, Nature genetics.

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

J. Vallon-Christersson, K. Isaksson, H. Jernström, 2024, Scientific reports.